SEC Filing Analysis: Guardant Health, Inc. (GH)

Executive Summary

• Trading Significance: Low
• Key Takeaway: The Chief Information Officer of Guardant Health executed a minor sale of common stock valued at approximately $209k.
• Market Impact: Neutral. The transaction is too small relative to the company's market capitalization to influence investor sentiment or stock price.

Company Information

Field	Value
Company	Guardant Health, Inc.
Ticker Symbol	GH
CIK	0001576280
Industry	Medical Laboratories

Insider Information

Field	Value
Name	Kalia Kumud
CIK	0001927831
Title/Position	Chief Information Officer
Relationship	Officer

Transaction Details

Field	Value
Form Type	4
Transaction Date	2025-12-08
Transaction Code	S (Open market or private sale of securities)
Security Type	Common Stock
Shares Involved	2,000
Price Per Share	$104.6021
Total Value	$209,204.20
Shares Owned After	22,365
Ownership Type	Direct

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$209,204.20
% of Market Cap	0.0017%
Shares Transacted	2,000
% of Shares Outstanding	Not available
Post-Transaction Ownership	22,365 shares
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: The transaction value of ~$209k is financially insignificant against Guardant Health's large-cap status of $12.26 billion.
• Ownership Concentration: The sale represents a minor reduction of approximately 8.2% of the insider's direct holdings. The post-transaction ownership remains substantial for the individual.
• Transaction Significance: Based on its value as a percentage of market capitalization (0.0017%), the transaction falls well below the 0.1% threshold for even moderate significance and is considered a routine portfolio adjustment.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: Insider sales of this small magnitude are common for liquidity or diversification purposes and do not typically signal a change in the insider's outlook on the company. The transaction size is negligible compared to daily trading volume and market cap.

Volume & Sentiment

• Expected Volume Impact: Negligible. The transaction size is too small to have a noticeable effect on trading volume.
• Sentiment Indicator: Neutral. The market is unlikely to react to this routine filing.

Additional Context

Transaction Notes

• Special Circumstances: The filing's footnote indicates the reported price is a weighted average. The shares were sold in multiple transactions at prices ranging from $104.58 to $104.75. No 10b5-1 trading plan was disclosed in relation to this sale.